乳腺病变中的浸润:上皮-间质屏障的作用
该综述聚焦于乳腺病理中肌上皮细胞(MEC)层与基底膜(BM)在区分原位癌与浸润性癌中的作用,指出MEC层在导管原位癌(DCIS)中可断裂或免疫表型改变,在微腺腺病、浸润性上皮增生症等良性病变及部分乳头状癌中也可缺失,因此不能单凭MEC特征判定浸润,需结合形态学与临床行为谨慎解读。
要点
- MEC层与BM是区分DCIS与浸润性癌的常用形态学依据,但识别并非总是一目了然。
- 微腺腺病、浸润性上皮增生症及部分乳头状癌中MEC可缺失,却不代表恶性或转移潜能。
- 不宜仅凭MEC特征将形态学良性病变改判为浸润性病变,须结合文献证据与临床行为。
核心结论
- MEC与BM是区分原位与浸润性病变的重要但非绝对标准,解读MEC特征需谨慎并结合形态学与临床行为证据。
研究设计与样本
- 本文为综述,围绕MEC与BM在乳腺病理诊断中的作用及潜在临床意义进行文献汇总与讨论。
主要发现
- DCIS周围MEC层可断裂或免疫表型改变,增加与原位/浸润鉴别难度。
- 微腺腺病、浸润性上皮增生症等良性局部浸润性病变中MEC可缺失,不提示恶性或转移潜能。
- 大汗腺病变等非浸润性情况偶见MEC缺失;部分乳头状癌MEC可缺失但行为惰性类似部分DCIS。
- Paget病中恶性乳腺上皮细胞向前累及乳头表皮,但通常不穿透BM进入真皮。
- 浸润性癌细胞及转移灶周围可见BM样物质。
临床怎么用
- 诊断原位与浸润时应综合形态学、MEC/BM免疫表型与病变已知临床行为,避免仅凭MEC缺失判定浸润。
局限性
- 本文为叙述性综述,未提供系统检索策略或定量汇总数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Despite the significant biological, behavioural and management differences between ductal carcinoma in situ (DCIS) and invasive carcinoma of the breast, they share many morphological and molecular similarities. Differentiation of these two different lesions in breast pathological diagnosis is based typically on the presence of an intact barrier between the malignant epithelial cells and stroma; namely, the myoepithelial cell (MEC) layer and surrounding basement membrane (BM). Despite being robust diagnostic criteria, the identification of MECs and BM to differentiate in-situ from invasive carcinoma is not always straightforward. The MEC layer around DCIS may be interrupted and/or show an altered immunoprofile. MECs may be absent in some benign locally infiltrative lesions such as microglandular adenosis and infiltrating epitheliosis, and occasionally in non-infiltrative conditions such as apocrine lesions, and in these contexts this does not denote malignancy or invasive disease with metastatic potential. MECs may also be absent around some malignant lesions such as some forms of papillary carcinoma, yet these behave in an indolent fashion akin to some DCIS. In Paget's disease, malignant mammary epithelial cells extend anteriorly from the ducts to infiltrate the epidermis of the nipple but do not typically infiltrate through the BM into the dermis. Conversely, BM-like material can be seen around invasive carcinoma cells and around metastatic tumour cell deposits. Here, we review the role of MECs and BM in breast pathology and highlight potential clinical implications. We advise caution in interpretation of MEC features in breast pathology and mindfulness of the substantive evidence base in the literature associated with behaviour and clinical outcome of lesions classified as benign on conventional morphological examination before changing classification to an invasive lesion on the sole basis of MEC characteristics.
引用
- Rakha EA, Miligy IM, Gorringe KL, et al. Invasion in breast lesions: the role of the epithelial-stroma barrier. Histopathology. 2018. PMID: 29197112. doi:10.1111/his.13446
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。